NUTRA PHARMA CORP. Shareholders' Equity
NUTRA PHARMA CORP. (NPHC) had Shareholders' Equity of -$21.21 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-19
- 2026-06-30: Stockholders' Equity Attributable to Parent -$21.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$17.26M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$16.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$16.35M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$21.21M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | -$17.26M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | -$16.83M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | -$16.35M 10-Q · filed 2026-04-06 | |
| 2025-06-30 | -$15.83M 10-Q · filed 2026-08-19 | |
| 2025-03-31 | -$16.21M 10-Q · filed 2026-08-19 | |
| 2024-12-31 | -$14.81M 10-Q · filed 2026-08-19 | |
| 2024-09-30 | -$14.82M 10-Q · filed 2026-04-06 | |
| 2024-06-30 | -$14.56M 10-Q · filed 2026-04-06 | |
| 2024-03-31 | -$14.19M 10-Q · filed 2026-03-25 | |
| 2023-12-31 | -$13.77M 10-K · filed 2026-05-20 | |
| 2023-09-30 | -$13.53M 10-Q · filed 2026-01-02 | |
| 2023-06-30 | -$13.25M 10-Q · filed 2026-01-02 | |
| 2023-03-31 | -$12.97M 10-Q · filed 2025-12-23 | |
| 2022-12-31 | -$12.38M 10-K · filed 2026-02-17 | |
| 2022-09-30 | -$15.61M 10-Q · filed 2025-10-28 | |
| 2022-06-30 | -$16.20M 10-Q · filed 2025-10-28 | |
| 2022-03-31 | -$15.77M 10-Q · filed 2025-10-23 | |
| 2021-12-31 | -$20.88M 10-K · filed 2025-11-24 | |
| 2021-09-30 | -$23.62M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | -$39.24M 10-Q · filed 2022-11-21 | |
| 2021-03-31 | -$42.90M 10-Q · filed 2022-08-22 | -$42.85M 10-Q · filed 2021-09-17 |
| 2020-12-31 | -$11.49M 10-K · filed 2025-09-03 | |
| 2020-09-30 | -$9.65M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$10.43M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$8.93M 10-Q · filed 2021-09-24 | |
| 2019-12-31 | -$11.70M 10-K · filed 2022-04-15 | |
| 2019-09-30 | -$8.13M 10-Q · filed 2021-08-12 | |
| 2019-06-30 | -$7.65M 10-Q · filed 2021-08-12 | |
| 2019-03-31 | -$6.30M 10-Q · filed 2021-08-05 | |
| 2018-12-31 | -$5.94M 10-K · filed 2021-09-08 | |
| 2018-09-30 | -$5.36M 10-Q · filed 2021-05-14 | -$5.36M 10-Q · filed 2018-11-19 |
| 2018-06-30 | -$5.10M 10-Q · filed 2021-05-14 | |
| 2018-03-31 | -$5.16M 10-Q · filed 2021-05-07 | |
| 2017-12-31 | -$5.41M 10-K · filed 2021-07-01 | |
| 2017-09-30 | -$5.04M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | -$5.24M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$5.04M 10-Q · filed 2017-05-17 | |
| 2016-12-31 | -$4.48M 10-K · filed 2018-04-17 | |
| 2016-09-30 | -$4.10M 10-Q · filed 2016-11-22 | |
| 2016-06-30 | -$4.19M 10-Q · filed 2016-08-22 | |
| 2016-03-31 | -$3.97M 10-Q · filed 2016-06-21 | |
| 2015-12-31 | -$3.57M 10-K · filed 2018-04-17 | |
| 2015-09-30 | -$4.92M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$4.53M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | -$3.54M 10-Q · filed 2015-05-19 | |
| 2014-12-31 | -$3.59M 10-K · filed 2017-04-17 | |
| 2014-09-30 | -$3.56M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$3.96M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$3.97M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | -$4.22M 10-K · filed 2016-04-14 | |
| 2013-09-30 | -$4.57M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$3.71M 10-Q · filed 2013-08-19 | |
| 2013-03-31 | -$3.83M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | -$3.58M 10-K · filed 2015-04-13 | |
| 2012-09-30 | -$3.95M 10-Q/A · filed 2012-12-12 | |
| 2012-06-30 | -$3.94M 10-Q/A · filed 2012-12-07 | |
| 2012-03-31 | -$3.90M 10-Q/A · filed 2012-11-28 | |
| 2011-12-31 | -$3.91M 10-K · filed 2014-03-31 | |
| 2011-09-30 | -$2.41M 10-Q · filed 2011-11-15 | |
| 2011-06-30 | -$2.37M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$2.53M 10-Q · filed 2013-05-20 | |
| 2009-12-31 | -$1.14M 10-Q · filed 2013-05-20 | |
| 2008-12-31 | -$2.56M 10-Q · filed 2013-05-20 |